HealthCor Management’s Rocket Pharmaceuticals RCKT Stock Holding History

HealthCor Management’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$979K	Sell	50,000 -395,140	-89%	-$7.28M	0.9%	15
2022 Q3	$7.1M	Buy	+445,140	New	+$6.95M	0.89%	33
2020 Q2	–	Sell	-369,639	Closed	-$5.16M	–	61
2020 Q1	$5.16M	Sell	369,639 -18,721	-5%	-$371K	0.22%	44
2019 Q4	$8.84M	Buy	+388,360	New	+$6.49M	0.32%	49

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management's RCKT Position: Q4 2022 in Review

HealthCor Management reduced its Rocket Pharmaceuticals (RCKT) stake by 89% in Q4 2022, selling an estimated $7.28M and leaving 50,000 shares worth $979K. The position accounts for 0.9% of the portfolio, ranked #15.

HealthCor Management first reported a position in RCKT in Q4 2019 and has held it in 4 quarters since. The position peaked at $8.84M in Q4 2019. 168 funds tracked by Wall St. Rank hold RCKT as of Q4 2022.

HealthCor Management held 50,000 shares of Rocket Pharmaceuticals worth $979K as of Q4 2022.
HealthCor Management sold 395,140 Rocket Pharmaceuticals shares in Q4 2022, an estimated $7.28M.
Rocket Pharmaceuticals made up 0.9% of HealthCor Management's portfolio in Q4 2022, its #15 holding.
HealthCor Management first reported a position in Rocket Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
HealthCor Management's Rocket Pharmaceuticals position peaked at $8.84M in Q4 2019.
168 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.